Cv Ingenuity Corp is categorized under Laboratory Equipment and Supplies-Manufacturers in Fremont, CA and active since 2013.
Cv Ingenuity Corp was established in 2013, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Laboratory Equipment and Supplies-Manufacturers business, which does work in the B2B market, and is classified as a Laboratory Equipment and Supplies-Manufacturers, under code number 337127 by the NAICS.
If you are seeking more information, feel free to contact Douglas Koo at the company’s single location by writing to 6531 Dumbarton Circle, Fremont, California CA 94555 or by phoning (508) 261-8000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cv Ingenuity Corp |
Contact Person: | Douglas Koo |
Address: | 6531 Dumbarton Circle, Fremont, California 94555 |
Phone Number: | (508) 261-8000 |
Website Address: | covidien.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Laboratory Equipment and Supplies-Manufacturers |
SIC Code: | 3821 |
NAICS Code: | 337127 |
Share This Business: |
Cv Ingenuity Corp was started in 2013 to provide professional Laboratory Equipment and Supplies-Manufacturers under the SIC code 3821 and NAICS code 337127. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Douglas Koo for inquiries that concern Cv Ingenuity Corp by calling the company number (508) 261-8000, as your correspondence is most welcome. Additionally, the physical location of the single location of Cv Ingenuity Corp can be found at the coordinates 37.550228,-122.059414 as well as the street address 6531 Dumbarton Circle in Fremont, California 94555.
For its online presence, you may visit Cv Ingenuity Corp’s website at covidien.com and engage with its social media outlets through on Twitter and on Facebook.